Recent News

• 03.17.2025 - Belite Bio, Inc Full Year 2024 Financial Result Conference Call
• 03.17.2025 - Belite Bio, Inc Full Year 2024 Financial Result Conference Call
• 03.11.2025 - Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
• 03.11.2025 - Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
• 03.10.2025 - Leerink Partners Global Biopharma Conference 2025
• 03.10.2025 - Leerink Partners Global Biopharma Conference 2025
• 03.04.2025 - Belite Bio to Participate in the Leerink Partners Global Healthcare Conference
• 03.04.2025 - Belite Bio to Participate in the Leerink Partners Global Healthcare Conference
• 02.27.2025 - Interim Analysis Results from the Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease
• 02.27.2025 - Interim Analysis Results from the Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease

Recent Filings

• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.06.2025 - EX-99.1 EX-99.1
• 01.27.2025 - 424B7 Prospectus [Rule 424(b)(7)]